201 related articles for article (PubMed ID: 34437551)
1. Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia.
Kahn SK; Cywes-Bentley C; Blodgett GP; Canaday NM; Turner-Garcia CE; Vinacur M; Cortez-Ramirez SC; Sutter PJ; Meyer SC; Bordin AI; Vlock DR; Pier GB; Cohen ND
PLoS One; 2021; 16(8):e0250133. PubMed ID: 34437551
[TBL] [Abstract][Full Text] [Related]
2. Serum Antibody Activity against Poly-
Cohen ND; Kahn SK; Cywes-Bentley C; Ramirez-Cortez S; Schuckert AE; Vinacur M; Bordin AI; Pier GB
Microbiol Spectr; 2021 Sep; 9(1):e0063821. PubMed ID: 34319137
[TBL] [Abstract][Full Text] [Related]
3. PNAG-specific equine IgG
Rocha JN; Dangott LJ; Mwangi W; Alaniz RC; Bordin AI; Cywes-Bentley C; Lawhon SD; Pillai SD; Bray JM; Pier GB; Cohen ND
Vaccine; 2019 Feb; 37(9):1142-1150. PubMed ID: 30691984
[TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled trial comparing Rhodococcus equi and poly-N-acetyl glucosamine hyperimmune plasma to prevent R equi pneumonia in foals.
Kahn SK; Cywes-Bentley C; Blodgett GP; Canaday NM; Turner-Garcia CE; Flores-Ahlschwede P; Metcalfe LL; Nevill M; Vinacur M; Sutter PJ; Meyer SC; Bordin AI; Pier GB; Cohen ND
J Vet Intern Med; 2021 Nov; 35(6):2912-2919. PubMed ID: 34738651
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of complement deposition and opsonophagocytic killing of Rhodococcus equi mediated by poly-N-acetyl glucosamine hyperimmune plasma compared to commercial plasma products.
Folmar CN; Cywes-Bentley C; Bordin AI; Rocha JN; Bray JM; Kahn SK; Schuckert AE; Pier GB; Cohen ND
J Vet Intern Med; 2019 May; 33(3):1493-1499. PubMed ID: 31034109
[TBL] [Abstract][Full Text] [Related]
6. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma.
Perkins GA; Yeager A; Erb HN; Nydam DV; Divers TJ; Bowman JL
Vet Ther; 2002; 3(3):334-46. PubMed ID: 12447842
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia.
Hooper-McGrevy KE; Giguere S; Wilkie BN; Prescott JF
Am J Vet Res; 2001 Aug; 62(8):1307-13. PubMed ID: 11497456
[TBL] [Abstract][Full Text] [Related]
8. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia.
Prescott JF; Nicholson VM; Patterson MC; Zandona Meleiro MC; Caterino de Araujo A; Yager JA; Holmes MA
Am J Vet Res; 1997 Apr; 58(4):356-9. PubMed ID: 9099378
[TBL] [Abstract][Full Text] [Related]
9. Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi.
Cywes-Bentley C; Rocha JN; Bordin AI; Vinacur M; Rehman S; Zaidi TS; Meyer M; Anthony S; Lambert M; Vlock DR; Giguère S; Cohen ND; Pier GB
PLoS Pathog; 2018 Jul; 14(7):e1007160. PubMed ID: 30024986
[TBL] [Abstract][Full Text] [Related]
10. Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals.
Caston SS; McClure SR; Martens RJ; Chaffin MK; Miles KG; Griffith RW; Cohen ND
Vet Ther; 2006; 7(4):361-75. PubMed ID: 17216591
[TBL] [Abstract][Full Text] [Related]
11. Failure of hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals.
Hurley JR; Begg AP
Aust Vet J; 1995 Nov; 72(11):418-20. PubMed ID: 8929188
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals.
Giguère S; Gaskin JM; Miller C; Bowman JL
J Am Vet Med Assoc; 2002 Jan; 220(1):59-63. PubMed ID: 12680449
[TBL] [Abstract][Full Text] [Related]
13. Immunoprophylaxis of Rhodococcus equi pneumonia in foals.
Becú T; Polledo G; Gaskin JM
Vet Microbiol; 1997 Jun; 56(3-4):193-204. PubMed ID: 9226834
[TBL] [Abstract][Full Text] [Related]
14. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.
Lopez AM; Hines MT; Palmer GH; Knowles DP; Alperin DC; Hines SA
Vaccine; 2003 Sep; 21(25-26):3815-25. PubMed ID: 12922115
[TBL] [Abstract][Full Text] [Related]
15. Effect of prophylactic administration of hyperimmune plasma to prevent Rhodococcus equi infection on foals from endemically affected farms.
Higuchi T; Arakawa T; Hashikura S; Inui T; Senba H; Takai S
Zentralbl Veterinarmed B; 1999 Nov; 46(9):641-8. PubMed ID: 10605374
[TBL] [Abstract][Full Text] [Related]
16. Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses.
Prescott JF; Fernandez AS; Nicholson VM; Patterson MC; Yager JA; Viel L; Perkins G
Equine Vet J; 1996 Sep; 28(5):344-9. PubMed ID: 8894530
[TBL] [Abstract][Full Text] [Related]
17. Transfusion With 2 L of Hyperimmune Plasma is Superior to Transfusion of 1 L or Less for Protecting Foals Against Subclinical Pneumonia Attributed to Rhodococcus equi.
Kahn SK; Blodgett GP; Canaday NM; Bevevino KE; Rocha JN; Bordin AI; Cohen ND
J Equine Vet Sci; 2019 Aug; 79():54-58. PubMed ID: 31405501
[TBL] [Abstract][Full Text] [Related]
18. VapA-specific IgG and IgG subclasses responses after natural infection and experimental challenge of foals with Rhodococcus equi.
Sanz MG; Villarino N; Ferreira-Oliveira A; Horohov DW
Vet Immunol Immunopathol; 2015 Mar; 164(1-2):10-5. PubMed ID: 25681111
[TBL] [Abstract][Full Text] [Related]
19. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
Cauchard J; Sevin C; Ballet JJ; Taouji S
Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
[TBL] [Abstract][Full Text] [Related]
20. Transfusion of hyperimmune plasma for protecting foals against Rhodococcus equi pneumonia.
Kahn SK; Cohen ND; Bordin AI; Coleman MC; Heird JC; Welsh TH
Equine Vet J; 2023 May; 55(3):376-388. PubMed ID: 35834170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
